Literature DB >> 14614746

Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters.

Te-Chun Hsia1, Hung-Chih Chiang, David Chiang, Liang-Wen Hang, Fuu-Jen Tsai, Wen-Chi Chen.   

Abstract

Lung cancer, a common malignancy in Taiwan, involves multiple factors, including genetics and environmental factors. The survival time is very short once cancer is diagnosed as being in advanced stage and surgically unresectable. Therefore, a good model of prediction of disease outcome is important for a treatment plan. We investigated the survival time in advanced lung cancer by using computer science from the genetic polymorphism of the p21 and p53 genes in conjunction with patients' general data. We studied 75 advanced and surgical unresectable lung cancer patients. The prediction of survival time was made by comparing real data obtained from follow-up periods with data generated by an artificial neural network (ANN). The most important input variable was the clinical staging of lung cancer patients. The second and third most important variables were pathological type and responsiveness to treatment, respectively. There were 25 neurons in the input layer, four neurons in the hidden layer-1, and one neuron in the output layer. The predicted accuracy was 86.2%. The average survival time was 12.44 +/- 7.95 months according to real data and 13.16 +/- 1.77 months based on the ANN results. ANN provides good prediction results when clinical parameters and genetic polymorphisms are considered in the model. It is possible to use computer science to integrate the genetic polymorphisms and clinical parameters in the prediction of disease outcome. Data mining provides a promising approach to the study of genetic markers for advanced lung cancer. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614746      PMCID: PMC6808159          DOI: 10.1002/jcla.10102

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  18 in total

1.  Genetic variations can point the way to disease genes.

Authors:  N Loder
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

2.  Lung cancer cell identification based on artificial neural network ensembles.

Authors:  Zhi Hua Zhou; Yuan Jiang; Yu Bin Yang; Shi Fu Chen
Journal:  Artif Intell Med       Date:  2002-01       Impact factor: 5.326

3.  Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach.

Authors:  E Biganzoli; P Boracchi; L Mariani; E Marubini
Journal:  Stat Med       Date:  1998-05-30       Impact factor: 2.373

4.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

5.  Reduction of false positives in computerized detection of lung nodules in chest radiographs using artificial neural networks, discriminant analysis, and a rule-based scheme.

Authors:  Y C Wu; K Doi; M L Giger; C E Metz; W Zhang
Journal:  J Digit Imaging       Date:  1994-11       Impact factor: 4.056

6.  Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery.

Authors:  R P Abratt; A Sandler; L Crinò; W P Steward; F A Shepherd; M R Green; B Nguyen; G J Peters
Journal:  Semin Oncol       Date:  1998-08       Impact factor: 4.929

7.  Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study.

Authors:  M Binder; A Steiner; M Schwarz; S Knollmayer; K Wolff; H Pehamberger
Journal:  Br J Dermatol       Date:  1994-04       Impact factor: 9.302

8.  Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.

Authors:  Y J Li; P Laurent-Puig; R J Salmon; G Thomas; R Hamelin
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

9.  p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.

Authors:  Y C Wang; C Y Chen; S K Chen; Y Y Chang; P Lin
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

10.  Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.

Authors:  C M Shih; P T Lin; H C Wang; W C Huang; Y C Wang
Journal:  Jpn J Cancer Res       Date:  2000-01
View more
  4 in total

1.  Machine learning for detecting gene-gene interactions: a review.

Authors:  Brett A McKinney; David M Reif; Marylyn D Ritchie; Jason H Moore
Journal:  Appl Bioinformatics       Date:  2006

2.  An overview of the use of artificial neural networks in lung cancer research.

Authors:  Luca Bertolaccini; Piergiorgio Solli; Alessandro Pardolesi; Antonello Pasini
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

3.  Machine learning application in personalised lung cancer recurrence and survivability prediction.

Authors:  Yang Yang; Li Xu; Liangdong Sun; Peng Zhang; Suzanne S Farid
Journal:  Comput Struct Biotechnol J       Date:  2022-04-04       Impact factor: 6.155

4.  Applications of machine learning in cancer prediction and prognosis.

Authors:  Joseph A Cruz; David S Wishart
Journal:  Cancer Inform       Date:  2007-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.